United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations. (2018). Examining HRSA's oversight of the 340B Drug Pricing Program: Hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, July 18, 2017. U.S. Government Publishing Office.
Chicago Style (17th ed.) CitationUnited States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations. Examining HRSA's Oversight of the 340B Drug Pricing Program: Hearing Before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, First Session, July 18, 2017. Washington: U.S. Government Publishing Office, 2018.
MLA (9th ed.) CitationUnited States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations. Examining HRSA's Oversight of the 340B Drug Pricing Program: Hearing Before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, First Session, July 18, 2017. U.S. Government Publishing Office, 2018.